INS and diabetes mellitus: The addition of the proinsulin sub-model was possible due to the many studies examining proinsulin and its role in diabetes pathophysiology, which also detailed the comparisons of proinsulin and insulin binding, potency, pharmacokinetics (PK), and pharmacodynamics [12].